Novel modifications in the alkenyldiarylmethane (ADAM) series of non- nucleoside reverse transcriptase inhibitors
In an effort to obtain more insight into the interaction between HIV-1 reverse transcriptase and the alkenyldiarylmethanes (ADAMs), a new series of compounds has been synthesized and evaluated for inhibition of HIV-1 replication. The modifications reporte
Casimiro-Garcia, Agustin,Micklatcher, Mark,Turpin, Jim A.,Stup, Tracy L.,Watson, Karen,Buckheit, Robert W.,Cushman, Mark
p. 4861 - 4874
(2007/10/03)
More Articles about upstream products of 252934-53-5